ËÑË÷

¹ý±í´ïÎÈתϸ°û

»ùÒò¹ý±í´ïÎÈתÖêÊÇÖ¸½«Ä¿µÄ»ùÒòÄÜÔÚϸ°ûÄÚºã¾ÃÇÒÎȹ̵عýÁ¿±í´ï£¬£¬£¬ÆäÔÚ»ùÒò¹¦Ð§Ñо¿¡¢¼²²¡Ä£×ӵĹ¹½¨¡¢Ò©Îïɸѡ¡¢ÂѰ×ÖÊÉú²úÒÔ¼°»ùÒòÖÎÁƵȶà¸öÁìÓòÓÐ×ÅÆÕ±éµÄÓ¦Óᣡ£¡£
ÍêÃÀÕæÈËÖÂÁ¦ÓÚΪ¿Í»§Ìṩ¸ßÖÊÁ¿µÄÎÈתϸ°ûϵ¹¹½¨Ð§ÀÍ£¬£¬£¬Á¬Ïµ¶àÄêϸ°ûÉúÎïѧÂÄÀú£¬£¬£¬½¨ÉèÁËÒ»Ì׳ÉÊìÎȹ̵ĻùÒò¹ý±í´ïʵÑéϵͳ£¬£¬£¬¿ÉÕë¶Ô¶àÖÖ²î±ðϸ°û£¨°üÀ¨ÄÑתȾϸ°û¡¢Ðü¸¡Ï¸°û£©£¬£¬£¬ÌṩÓÅÖʵĻùÒò¹ý±í´ïϸ°û¹¹½¨Ð§ÀÍ¡£¡£¡£

ЧÀÍÏêÇé

ϸ°ûÀàÐÍ ÖÖÖÖϸ°ûÀàÐÍ£¬£¬£¬°üÀ¨Ö×Áö¡¢Í¨Àý¡¢¸Éϸ°û¡¢Ô­´úºÍÓÀÉú»¯Ï¸°ûϵ¡£¡£¡£
ЧÀÍÀàÐÍ ORFÎÈתϸ°ûϵ/CRISPRaÎÈתϸ°ûϵ
½»¸¶±ê×¼ 1£©»ùÒò¹ý±í´ï¶à¿Ë¡ϸ°ûpool£¨2¹Üϸ°û/Ö꣬£¬£¬1¡Á10^6/¹Ü£©
2£©»ùÒò¹ý±í´ïµ¥¿Ë¡ϸ°û¡Ý1Ö꣨2¹Üϸ°û/Ö꣬£¬£¬1¡Á10^6/¹Ü£©
3£©ÊµÑ鱨¸æ
ÖÜÆÚ/¼ÛÇ® ¿ìÖÁ4ÖÜ£¬£¬£¬6880ÔªÆð ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾? ÔÚÏß×Éѯ
ÍêÃÀÕæÈËÖÂÁ¦ÓÚΪ¿Í»§Ìṩ¸ßÖÊÁ¿µÄÎÈתϸ°ûϵ¹¹½¨Ð§ÀÍ£¬£¬£¬Á¬Ïµ¶àÄêϸ°ûÉúÎïѧÂÄÀú£¬£¬£¬½¨ÉèÁËÒ»Ì׳ÉÊìÎȹ̵ĻùÒò¹ý±í´ïʵÑéϵͳ£¬£¬£¬¿ÉÕë¶Ô¶àÖÖ²î±ðϸ°û£¨°üÀ¨ÄÑתȾϸ°û¡¢Ðü¸¡Ï¸°û£©£¬£¬£¬ÌṩÓÅÖʵĻùÒò¹ý±í´ïϸ°û¹¹½¨Ð§ÀÍ¡£¡£¡£

ЧÀÍÓÅÊÆ

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
¶àÖֹǼÜÔØÌåÑ¡Ôñ
¸»ºñµÄ¹Ç¼ÜÔØÌå¿â£¬£¬£¬°üÀ¨Âý²¡¶¾ÔØÌåºÍת×ù×ÓÔØÌåµÈÔØÌåÀàÐÍ£¬£¬£¬²¢´øÓжàÖÖÆô¶¯×Ó¡¢Ó«¹â±êÇ©¡¢¿¹ÐÔ»ùÒòµÈÑ¡Ôñ£¬£¬£¬Ëõ¶ÌʵÑéÖÜÆÚ¡£¡£¡£
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
¸ßЧµÄµ¥¿Ë¡·ÖÑ¡¼¼Êõ
3D´òÓ¡¼¼Êõ¸¨Öúµ¥¿Ë¡·ÖÑ¡£¡£¡£¬£¬£¬1·ÖÖÓ¼´¿ÉÍê³Éϸ°ûÆÌ°å£¬£¬£¬Ï¸°û´æ»îÂÊÊǹŰåÒªÁìµÄ3±¶ÒÔÉÏ¡£¡£¡£²¢ÇÒÿ¸ö¿Ë¡¾ùÓÐͼÏñ£¬£¬£¬È·±£ÊǼòµ¥¿Ë¡
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
¸ßЧµÄϸ°ûתȾ
¶À¼ÒÓÅ»¯×ªÈ¾ÔØÏµÒ»ÇУ¬£¬£¬²¢¾ßÓÐÊý°ÙÖÖϸ°ûתȾÂÄÀú£¬£¬£¬¿É¸ßЧµÝËͱí´ïÔØÌå
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
ÍŶÓÂÄÀú¸»ºñ
רҵµÄÍŶӣ¬£¬£¬ÓµÓÐ1000+»ùÒò±à¼­CROÏîÄ¿ÂÄÀú

ЧÀÍÀàÐÍ

¿Éƾ֤¿Í»§ÐèÇ󣬣¬£¬²¢×ۺϻùÒòºÍϸ°ûµÈÇéÐΣ¬£¬£¬Éè¼Æ»ùÒò¹ý±í´ï¼Æ»®¡£¡£¡£
 

ORF¹ý±í´ïϸ°ûϵÊÇÖ¸½«ÍâÔ´Ä¿µÄ»ùÒòµÄijת¼±¾ÎȹÌÕûºÏµ½ËÞÖ÷ϸ°û»ùÒò×éÖУ¬£¬£¬Ê¹ÆäÒ»Á¬¸ßЧ±í´ï¡£¡£¡£´ËÀàϸ°û¿ÉÔÚºã¾Ã´«´ú£¨Ô¼>30´ú£©»òÒ©ÎïɸѡÖмá³ÖÄ¿µÄ»ùÒòµÄÎȹ̱í´ï£¬£¬£¬¿ÉÒÔͨ¹ýÂý²¡¶¾ÏµÍ³»òÕßת×ù×Óϵͳ¹ý±í´ï»ùÒòµÄij¸öת¼±¾ÊµÏÖ¡£¡£¡£¹ý±í´ïÎÈתÖêµÄ½¹µã¿ÆÑ§¼ÛÖµÔÚÓÚͨ¹ýÍâÔ´»ùÒòµÄ»ùÒò×éÕûºÏ£¬£¬£¬Í»ÆÆÏ¸°û×Ô¼ºÄÚÔ´µ÷¿ØÏÞÖÆ£¬£¬£¬ÊµÏÖºã¾Ã¡¢Îȹ̡¢³¬¸ßˮƽµÄ»ùÒò±í´ï¡£¡£¡£Ö»¹Ü±£´æ²åÈëÍ»±äºÍ±í´ïĬȻµÈÌôÕ½£¬£¬£¬ÆäÈÔÊÇÑо¿»ùÒò¹¦Ð§¡¢¹¹½¨¼²²¡Ä£×Ӻ͹¤Òµ¼¶ÂѰ×Éú²úµÄ½ð±ê×¼¹¤¾ß¡£¡£¡£ ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾  ÁªÏµÍêÃÀÕæÈË

ЧÀÍÁ÷³Ì

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾ ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

CRISPRa£¨CRISPR activation£©ÊÇÒ»ÖÖ»ùÓÚCRISPRϵͳµÄ»ùÒòµ÷¿Ø¼¼Êõ£¬£¬£¬ËüʹÓþ­ÓÉˢеÄdCas9ÂѰף¨Ê§»îµÄCas9£©Óëµ¥µ¼ÏòRNA£¨sgRNA£©Á¬Ïµ£¬£¬£¬°ÐÏò²¢Á¬Ïµµ½Ä¿µÄ»ùÒòµÄת¼ÆðʼλµãÖÜΧ£¬£¬£¬Í¬Ê±dCas9ÈÚºÏת¼¼¤»îÒò×Ó£¨ÈçVP64, p65, RtaµÈ£¬£¬£¬»òʹÓúϳɵ碌îÒò×ÓÈçSAMϵͳ£©£¬£¬£¬¼¤»îϸ°û×Ô¼ºÄÚÔ´»ùÒòµÄ¹ý±í´ï¡£¡£¡£Í¨¹ýÉè¼ÆÌØ¶¨µÄsgRNA£¬£¬£¬CRISPRa¿Éͬʱ°ÐÏò¶à¸ö»ùÒòλµã£¬£¬£¬ÊµÏÖÖØ´ó»ùÒòÍøÂçµÄЭͬµ÷¿Ø£¬£¬£¬Îª¹¦Ð§»ùÒò×éѧÑо¿ÌṩÁËǿʢ¹¤¾ß¡£¡£¡£

ЧÀÍÁ÷³Ì

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

Àֳɰ¸Àý

 

½«CopEGFP»ùÒòÐòÁпË¡ÖÁÂý²¡¶¾±í´ïÔØÌåpLV3-CAG-MCS-P2A-PuroÖУ¬£¬£¬°ü×°Éú²ú¸ßµÎ¶ÈÂý²¡¶¾¿ÅÁ££¬£¬£¬²¢Ñ¬È¾ÈËÐþÉ«ËØÁöϸ°ûϵA375¡£¡£¡£Í¨¹ýÓ«ÏÊÃ÷΢¾µÖ±½ÓÊÓ²ìѬȾºóϸ°ûÖÐEGFP±¨¸æ»ùÒòµÄ±í´ïÇéÐΣ¬£¬£¬ÆÀ¹À¹ý±í´ïЧÂÊ¡£¡£¡£

×¢£º±¾°¸ÀýÖÐʹÓõÄA375-copEGFPϸ°ûΪÍêÃÀÕæÈ˹«Ë¾ÌṩµÄÏÖ»õϸ°û£¨»õºÅ£ºEDC01053£©£¬£¬£¬°ü¹ÜʵÑéµÄ¿ìËÙ¿ªÕ¹Óë¿ÉÖØ¸´ÐÔ¡£¡£¡£copGFP¹ý±í´ïϸ°ûÏÖ»õ¿â

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

ͼ1£ºpLV3-CAG-MCS-P2A-Puro¹Ç¼ÜÔØÌåͼÆ×

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

ͼ2£ºA375ϸ°ûÃ÷³¡Í¼Æ¬

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

ͼ3£ºA375-copEGFPϸ°ûͼƬ

½«Ä¿µÄ»ùÒòSCN10AµÄ±àÂëÐòÁпË¡ÖÁÂý²¡¶¾±í´ïÔØÌåpLV-EF1a-MCS-3×flag-puroÖУ¬£¬£¬¹¹½¨C¶ËÈÚºÏ3×Flag±êÇ©µÄ±í´ïÔØÌå¡£¡£¡£°ü×°»ñµÃ¸ßµÎ¶ÈÂý²¡¶¾¿ÅÁ£ºó£¬£¬£¬Ñ¬È¾ÈËÅßÉöϸ°ûHEK293T¡£¡£¡£Í¨¹ýÂѰ×ÖÊÃâÒßÓ¡¼££¨Western Blot, WB£©Ê¹Óÿ¹Flag¿¹Ìå¼ì²âÈÚºÏÂѰ׵ıí´ïˮƽ£¬£¬£¬ÒÔÑé֤ĿµÄ»ùÒòµÄ¹ý±í´ïЧÂÊ¡£¡£¡£

×¢£º±¾°¸ÀýÖÐʹÓõÄSCN10A»ùÒò¹ý±í´ïHEK293Tϸ°ûΪÍêÃÀÕæÈ˹«Ë¾ÌṩµÄÏÖ»õϸ°û£¨»õºÅ£ºEDC01474£©£¬£¬£¬°ü¹ÜʵÑéµÄ¿ìËÙ¿ªÕ¹Óë¿ÉÖØ¸´ÐÔ¡£¡£¡£¹ý±í´ïϸ°ûÏÖ»õ¿â

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

ͼ1£ºpLV-EF1a-MCS-3×flag-puro¹Ç¼ÜÔØÌåͼÆ×

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

ͼ2£ºWBÑé֤Ч¹û

½ÓÄÉÂý²¡¶¾ÔØÌå½éµ¼µÄCRISPR¼¤»î£¨CRISPRa£©ÏµÍ³ÊµÏÖLRP1»ùÒòµÄÌØÒìÐÔת¼ÔöÇ¿¡£¡£¡£

¢Ù½¹µãЧӦÆ÷µÝËÍ£º »®·ÖʹÓÃÂý²¡¶¾ÔØÌåEDV1951-lenti (±í´ïdCAS-VP64_Blast) ºÍ EDV2939-lentiMPH v2 (±í´ïMS2-P65-HSF1ÈÚºÏÂѰ×v2) °ü×°²¡¶¾¿ÅÁ££¬£¬£¬¹²Ñ¬È¾Ä¿µÄϸ°ûϵ£¬£¬£¬½¨ÉèÎȹ̱í´ïdCAS-VP64ºÍMPH v2ЧӦÆ÷¸´ºÏÎïµÄϸ°ûÖ꣨Blasticidin¼°hygroɸѡ£¡£¡£©¡£¡£¡£

¢Ú°ÐÏòsgRNAµÝËÍÓëɸѡ£¡£¡£º Õë¶ÔLRP1»ùÒòÆô¶¯×Ó/µ÷¿ØÇøÓò£¬£¬£¬Éè¼ÆÈýÌõ²î±ðµÄµ¥Ïòµ¼RNA (sgRNA)¡£¡£¡£½«Ã¿ÌõsgRNAÐòÁл®·Ö¿Ë¡ÖÁÂý²¡¶¾sgRNA±í´ïÔØÌåEDV3689-Lenti sgRNA(MS2)-PuroÖУ¬£¬£¬¹¹½¨°ÐÏòLRP1µÄsgRNA±í´ïÔØÌå¡£¡£¡£»®·Ö°ü×°ÈýÖÖÂý²¡¶¾²¢Ñ¬È¾ÒÑÎȹ̱í´ïdCAS-VP64/MPH v2µÄϸ°û£¬£¬£¬Í¨¹ýPuromycinɸѡ»ñµÃÎȹÌÕûºÏ²î±ðsgRNAµÄϸ°ûÖê¡£¡£¡£

¢Û¼ì²â£º ͨ¹ýqRT-PCR¼ì²âLRP1»ùÒòÔÚmRNA¼°ÂѰ×ˮƽµÄ±í´ïת±ä¡£¡£¡£¼ì²âЧ¹û֤ʵÁ˸ÃϵͳÔÚÄ¿µÄϸ°ûÖÐÓÐÓü¤»îÁËLRP1»ùÒòµÄ±í´ï¡£¡£¡£¹ý±í´ïϸ°ûÏÖ»õ¿â

EDV3689-Lenti sgRNA(MS2)-Puro¹Ç¼ÜÔØÌåͼÆ×

ͼ1£ºEDV3689-Lenti sgRNA(MS2)-Puro¹Ç¼ÜÔØÌåͼÆ×

 qRT-PCRÑé֤Ч¹ûչʾ¸Ã»ùÒòÀֳɱ»¼¤»î±í´ï

ͼ2£º qRT-PCRÑé֤Ч¹ûչʾ¸Ã»ùÒòÀֳɱ»¼¤»î±í´ï

Àֳɰ¸Àý

¢Ù ÔÚA549ϸ°ûÖйý±í´ïCopGFP
1£©ÔØÌåͼÆ×
 
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
 
 
 
 
2£©¹ý±í´ïЧ¹û
 
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
 
Ã÷³¡Í¼Æ¬
 
 
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
 
GFPÓ«¹âͼƬ
 
 
¢Ú ÔÚHCT116ϸ°ûÖйý±í´ïCopGFP
1£©ÔØÌåͼÆ×
 
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
 
 
 
2£©¹ý±í´ïЧ¹û
 
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
 
Ã÷³¡Í¼Æ¬
 
 
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
 
GFPÓ«¹âͼƬ

Advantage and Characteristic

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
Optimazied Strategy
We have create a unique sgRNA Design Logic
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
Optimazied Strategy
We have create a unique sgRNA Design Logic
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
Optimazied Strategy
We have create a unique sgRNA Design Logic
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
Optimazied Strategy
We have create a unique sgRNA Design Logic

²Î¿¼ÎÄÏ×

High Expression of SRSF10 Promotes Colorectal Cancer Progression by Aberrant Alternative Splicing of RFC5

±¾Ñо¿Ö¼ÔÚ̽ÌÖ¸»º¬Ë¿°±ËáºÍ¾«°±ËáµÄ¼ô½ÓÒò×Ó10£¨SRSF10£©ÔÚ½áÖ±³¦°©£¨CRC£©ÖеÄ×÷Óü°Æä·¢²¡»úÖÆ¡£¡£¡£Í¨¹ýÉúÎïÐÅϢѧÆÊÎöÕ¹ÍûCRC»¼ÕßÖÐSRSF10»ùÒòµÄ±í´ïÇéÐΣ¬£¬£¬½ÓÄÉCCK8¡¢Transwell¡¢»®ºÛʵÑéºÍÁ÷ʽϸ°ûÊõ¾ÙÐÐSRSF10»ùÒòÇõͺ͹ý±í´ïµÄ¹¦Ð§ÊµÑ飬£¬£¬²¢Í¨¹ýÇíÖ¬ÌÇÄý½ºµçÓ¾Åжϲî±ðµÄSRSF10×÷ÓÃÓÚRFC5ǰmRNAµÄת¼±¾¡£¡£¡£Ð§¹ûÏÔʾ£¬£¬£¬ÇõÍSRSF10ÒÖÖÆÁËCRCϸ°ûµÄÔöÖ³ºÍǨáãÄÜÁ¦£¬£¬£¬Ôö½øÁËϸ°ûµòÍö²¢¸Ä±äÁËCRCϸ°ûµÄDNA¸´ÖÆ£»£»£» £»¶øSRSF10µÄ¸ß±í´ïÔòÔöÇ¿ÁËCRCϸ°ûµÄÔöÖ³ºÍǨáãÄÜÁ¦£¬£¬£¬²¢ÒýÆðϸ°ûÖÜÆÚµÄת±ä¡£¡£¡£ÌØÊâÊÇ£¬£¬£¬¸ß±í´ïSRSF10½µµÍÁË×÷Óýϸ°ûÖÐµÄÆÏÌÑÌÇÉãÈ¡£¡£¡£¬£¬£¬½øÒ»²½Åú×¢ÆäÔÚÄÜÁ¿´úлÖеĸºµ÷Àí×÷Óᣡ£¡£±¾Ñо¿»¹Õ¹ÏÖÁËÔÚSRSF10Çõͺ󣬣¬£¬½áÖ±³¦°©Ï¸°ûÖеÄRFC5»ùÒò±¬·¢ÁËת±ä£¬£¬£¬SRSF10ÔöÌíÁËRFC5ÍâÏÔ×Ó2-AS1(S)ת¼±äÌ壬£¬£¬´Ó¶øÍ¨¹ýAS1ɨ³ýÔö½øÁËRFC5ÍâÏÔ×Ó2µÄÒì³£¼ô½Ó£¬£¬£¬Íƶ¯ÁËÈ´Ö±³¦°©µÄÉú³¤¡£¡£¡£Ñо¿Åú×¢£¬£¬£¬SRSF10ͨ¹ýÌìÉúRFC5ÍâÏÔ×Ó2ÖеÄÒì³£¼ô½ÓÒì¹¹ÌåÔö½øÁËÈ´Ö±³¦°©µÄÏ£Íû£¬£¬£¬ÌáÐÑSRSF10¿ÉÄܳÉΪCRCÁÙ´²Õï¶ÏºÍÖÎÁƵÄÖ÷Òª°Ðµã¡£¡£¡£

The alteration of LBX1 expression is associated with changes in parameters related to energy metabolism in mice

LBX1»ùÒòλÓÚÓëÇàÉÙÄêÌØ·¢ÐÔ¼¹Öù²àÍäÒ׸ÐÐԸ߶ÈÏà¹ØµÄµ¥ºËÜÕËá¶à̬ÐÔÖÜΧ£¬£¬£¬±»ÒÔΪÊÇÕâÒ»¼²²¡·¢²¡»úÖÆÖÐ×îÇ¿µÄºòÑ¡»ùÒòÖ®Ò»¡£¡£¡£Ñо¿·¢Ã÷£¬£¬£¬LBX1ȱʧ²»µ«µ¼Ö¼¹Öù»ûÐΣ¬£¬£¬»¹Ó°ÏìÊÝÌåÖØ£¬£¬£¬ÌáÐÑLBX1ÔÚÄÜÁ¿´úлÖпÉÄÜʩչ×÷Óᣡ£¡£±¾Ñо¿Ö¼ÔÚ̫ͨ¹ýÎöȱʧLBX1µÄ¹Ç÷À¼¡Ð¡ÊóµÄ±íÐÍÀ´ÑéÖ¤ÕâÒ»¼ÙÉ裬£¬£¬ÖØµã¹Ø×¢ÄÜÁ¿´úл¡£¡£¡£Ð§¹ûÏÔʾ£¬£¬£¬LBX1ȱʧµÄСÊó¶Ô¸ßÖ¬ÒûʳÓÕµ¼µÄ·ÊÅÖÌåÏÖ³ö¸üÇ¿µÄ¶Ô¿¹Á¦£¬£¬£¬Ö»¹ÜÍ»±äСÊóÓë±ÈÕÕСÊóµÄʳÎïÉãÈëÁ¿Ï൱¡£¡£¡£Í»±äСÊóµÄÆÏÌÑÌÇÄÍÊÜÐÔ¸üºÃ¡¢×î´óÓÐÑõÄÜÁ¦¸ü¸ß¡¢½¹µãÌåθü¸ß¡£¡£¡£±ðµÄ£¬£¬£¬LBX1µÄ¹ý±í´ï½µµÍÁË×÷Óýϸ°ûÖÐµÄÆÏÌÑÌÇÉãÈ¡¡£¡£¡£×ÛºÏÊý¾ÝÅú×¢£¬£¬£¬LBX1×÷ΪÄÜÁ¿´úлµÄ¸ºµ÷ÀíÒò×Ó£¬£¬£¬ÆäȱʧÔöÌíÁËϵͳÐÔÄÜÁ¿ÏûºÄ£¬£¬£¬´Ó¶øµ¼ÖÂÊÝÌåÖØ¡£¡£¡£Òò´Ë£¬£¬£¬±¾Ñо¿ÌáÐÑÁËLBX1¹¦Ð§Õϰ­ÓëÇàÉÙÄêÌØ·¢ÐÔ¼¹Öù²àÍ仼ÕßÊÝÌåÖØÖ®¼äµÄDZÔÚ¹ØÁª¡£¡£¡£

Vasorin (VASN) overexpression promotes pulmonary metastasis and resistance to adjuvant chemotherapy in patients with locally advanced rectal cancer

ÕâÏîÑо¿Ì½ÌÖÁËVASNÔÚÖ±³¦°©ÖеÄ×÷Ó㬣¬£¬·¢Ã÷Æä¸ß±í´ïÓë·Î×ªÒÆºÍ»¯ÁÆÄÍÒ©ÐÔÏà¹Ø¡£¡£¡£Í¨¹ý½¨Éè¹ý±í´ïºÍÇõÍVASNµÄÎÈתÖ꣬£¬£¬×÷Õß½øÒ»²½ÑéÖ¤ÁËVASNÔÚÔö½ø°©Ï¸°ûǨáã¡¢ÇÖÏ®ºÍÔöÖ³·½ÃæµÄ×÷Óᣡ£¡£ÌåÄÚºÍÌåÍâʵÑéЧ¹ûÏÔʾ£¬£¬£¬VASNµÄ¹ý±í´ïÏÔÖøÔöÇ¿Á˰©Ï¸°ûµÄÇÖÏ®ÄÜÁ¦£¬£¬£¬²¢½µµÍÁ˶Ի¯ÁÆÒ©ÎïµÄÃô¸ÐÐÔ¡£¡£¡£ÊµÑéÒªÁì°üÀ¨Ê¹ÓÃÂý²¡¶¾ÔØÌåתȾVASN»ùÒò£¬£¬£¬²¢Í¨¹ýG418¿¹ÐÔɸѡ½¨ÉèÎȹÌϸ°ûÖ꣬£¬£¬Ê¹ÓÃWestern blotºÍqPCRÑéÖ¤VASN¹ý±í´ï¡£¡£¡£

¾«Ñ¡¿Í»§ÎÄÕÂ

IF=50.5
nature

È«ÇòÁè¼ÝÒ»°ëµÄ¸Îϸ°û°©£¨HCC£©²¡Àý±¬·¢ÔÚÖйú£¬£¬£¬µ«ÏÖÔÚÕë¶ÔÖйúÈËȺÖÐÒÒÐ͸ÎÑײ¡¶¾£¨HBV£©Ïà¹ØHCCµÄÈ«»ùÒò×éÆÊÎöÑо¿ºÜÊÇÓÐÏÞ¡£¡£¡£ÎªÁËÍ»ÆÆÕâÖÖÏÞÖÆ£¬£¬£¬Ñо¿Ö°Ô±Æô¶¯ÁË“Öйú¸Î°©Í¼Æ×ÏîÄ¿”£¨CLCA£©£¬£¬£¬Ö¼ÔÚ¶ÔÖйúÈËȺÖеÄHCC¾ÙÐдó¹æÄ£µÄÈ«»ùÒò×éÆÊÎöÒÔÃ÷È·ÆäÆæÒìµÄ·¢²¡»úÖÆºÍ½ø»¯Àú³Ì¡£¡£¡£¸ÃÏîÄ¿¶Ô494ÀýHCCÖ×ÁöÑù±¾¾ÙÐÐÁËÉî¶ÈÈ«»ùÒò×é²âÐò£¨Æ½¾ù²âÐòÉî¶ÈΪ120×£©£¬£¬£¬²¢ÆÊÎöÁËÆ¥ÅäµÄ±ÈÕÕѪҺÑù±¾£¬£¬£¬Õ¹ÏÖÁËHBVÏà¹ØHCCµÄÏêϸ»ùÒò×éÌØÕ÷¡£¡£¡£Ñо¿·¢Ã÷£¬£¬£¬³ýÁËÒÑÖªµÄ±àÂëÇøÇý¶¯»ùÒò£¨ÈçTP53ºÍCTNNB1£©Í⣬£¬£¬»¹±£´æ6¸öеıàÂëÇøÇý¶¯»ùÒò£¨°üÀ¨FGA£©ºÍ31¸ö·Ç±àÂëÇøÇý¶¯»ùÒò¡£¡£¡£±ðµÄ£¬£¬£¬Ñо¿»¹Õ¹ÏÖ5ÖÖеÄÍ»±äÌØÕ÷£¨°üÀ¨SBS_H8£©£¬£¬£¬ÒÔ¼°HBVÕûºÏÐγÉϸ°ûÍâ»·×´DNA£¨ecDNA£©µÄÕ÷Ï󣬣¬£¬ÕâЩecDNA¿Éµ¼Ö°©»ùÒòÀ©ÔöºÍ±í´ïÔöÌí¡£¡£¡£Í¨¹ý¹¦Ð§Ñé֤ʵÑ飬£¬£¬Ñо¿Ö°Ô±Ö¤ÊµÁËFGA¡¢PPP1R12BºÍKCNJ12µÈ»ùÒòµÄÍ»±äÄܹ»ÏÔÖøÓ°ÏìHCCϸ°ûµÄÔöÖ³¡¢Ç¨áãºÍÇÖÏ®ÄÜÁ¦¡£¡£¡£ÕâÏîÑо¿Ð§¹û²»µ«¸»ºñÁËÈËÃǶÔHCC»ùÒò×éѧµÄÃ÷È·£¬£¬£¬Ò²ÎªHCCµÄÕï¶ÏºÍÖÎÁÆÌṩÁËеÄDZÔڰе㡣¡£¡£

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

ºòÑ¡Çý¶¯Òò×Ӹſö

IF=27.4
Advanced material

¼¡ëìËðÉ˼±ÐÔÑ×Ö¢ÆÚÖУ¬£¬£¬¾ÞÊÉϸ°ûÌ«¹ý¼¤»î»áµ¼Ö±àÂë¹ÇÇÅÂѰ×OPNµÄSPP1¹ý±í´ï£¬£¬£¬Ó°Ïì×éÖ¯ÔÙÉú¡£¡£¡£CRISPR-Cas13ÓÉÓÚ¾ßÓÐRNA±à¼­ºÍ¿ìËÙ½µ½âµÄÄÜÁ¦£¬£¬£¬ÔÚ×éÖ¯ÐÞ¸´·½Ãæ¾ßÓÐÖØ´óDZÁ¦£¬£¬£¬µ«È±·¦ºÏÊÊÓÐÓõĵÝËÍÒªÁì¡£¡£¡£¶Ô´Ë£¬£¬£¬Ñо¿Ö°Ô±ÏµÍ³É¸Ñ¡ÁËÕë¶Ô¾ÞÊÉϸ°ûµÄÑôÀë×Ó¾ÛºÏÎ£¬£¬¿ª·¢ÁËÒ»ÖÖÄܹ»¸ßЧµÝËÍCas13ºËÌǺËÂѰ׸´ºÏÎCas13 RNP£©½øÈë¾ÞÊÉϸ°ûµÄÄÉÃ×´ØÔØÌå¡£¡£¡£Í¨¹ý·´Ó¦ÐÔÑõÖÖ£¨ROS£©ÏìÓ¦ÐÔÊÍ·Å»úÖÆ£¬£¬£¬¸ÃϵͳÄܹ»ÔÚ¼¡ëìËðÉ˵ļ±ÐÔÑ×֢΢ÇéÐÎÖÐÌØÒìÐÔÒÖÖÆ¾ÞÊÉϸ°ûÖÐSPP1µÄ¹ý±í´ï¡£¡£¡£ÊµÑéЧ¹ûÅú×¢£¬£¬£¬ÕâÖÖ°ÐÏò²ßÂÔÏÔÖøïÔÌ­ÁËËðÉËÓÕµ¼µÄSPP1±¬·¢¾ÞÊÉϸ°ûµÄ·ºÆð£¬£¬£¬½µµÍÁ˳ÉÏËάϸ°ûµÄ¼¤»î£¬£¬£¬²¢¼õÇáÁ˼¡ëìÖÜΧµÄÕ³Á¬Ðγɡ£¡£¡£±ðµÄ£¬£¬£¬¸ÃÑо¿»¹Õ¹ÏÖÁËSPP1ͨ¹ýCD44/AKTÐźÅͨ·Ôö½ø³ÉÏËάϸ°û»î»¯ºÍǨáãµÄ»úÖÆ£¬£¬£¬²¢Í¨¹ýÒÖÖÆÕâһͨ·ÓÐÓûº½âÁ˼¡ëìËðÉ˺óµÄÕ³Á¬ÎÊÌâ¡£¡£¡£

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

ÓÃÓÚPAÖÎÁƵľÞÊÉϸ°ûÃâÒß΢ÇéÐ줻îmRNA±à¼­²ßÂÔµÄʾÒâͼ

IF=12.8
Biomaterials

¼¹ËèËðÉË£¨SCI£©ÊÇÒ»ÖÖµ¼Ö¸ÐÊÜ×ÔÖ÷Éñ¾­ºÍÔ˶¯¹¦Ð§µÄÓÀÊÀÐÔË𺦵ÄÑÏÖØÖ²ÐÐÔ¼²²¡¡£¡£¡£¸Éϸ°ûÁÆ·¨£¬£¬£¬ÓÈÆäÊǼä³äÖʸÉϸ°û£¨MSCs£©£¬£¬£¬ÔÚSCIÖÎÁÆÖÐÕ¹ÏÖ³öÖØ´óDZÁ¦µ«ÆäÔÙÉúÄÜÁ¦ÓÐÏÞ£¬£¬£¬ÕâÏÞÖÆÁËÆäÔÚ×éÖ¯ÔÙÉúÖеÄÓ¦Óᣡ£¡£Ñо¿ÍŶÓÊӲ쵽ABPCsÑÜÉúµÄEVs£¨EVsABPC£©¿ÉÄÜЯ´øÔö½ø×éÖ¯ÔÙÉúµÄÉúÎï»îÐÔÐźţ¬£¬£¬Òò´ËËûÃÇ´Ó¹½ÇÑ¿»ù×æÏ¸°û£¨ABPCs£©ÖÐÌáÈ¡²¢ÐÞÊÎÁËϸ°ûÍâÄÒÅÝ£¨EVsABPC£©£¬£¬£¬²¢½«ÆäÓ¦ÓÃÓÚ¼¹ËèËðÉË£¨SCI£©µÄÖÎÁÆÑо¿¡£¡£¡£Ñо¿Ö°Ô±·¢Ã÷EVsABPCÄܹ»ÏÔÖøÔöÇ¿Éñ¾­¸Éϸ°û£¨NSCs£©µÄÔöÖ³£¬£¬£¬Ôö½øÖáÍ»Éú³¤£¬£¬£¬ïÔÌ­Éñ¾­ÔªµòÍö£¬£¬£¬²¢Í¨¹ýµ÷ÀíÑ×Ö¢·´Ó¦½«¾ÞÊÉϸ°û´Ó´ÙÑ×µÄM1Ðͼ«»¯Îª¿¹Ñ×µÄM2ÐÍ¡£¡£¡£±ðµÄ£¬£¬£¬¾­Óɹ¤³Ì»¯Ë¢ÐµÄEVsABPC£¨Í¨¹ý¼¤»îϸ°û´©Í¸ëÄÐÞÊΣ©Äܹ»¸üÓÐÓõذÐÏòSCIËðÉ˲¿Î»£¬£¬£¬ÏÔÖø¸ÄÉÆÉñ¾­ÔÙÉúºÍÔ˶¯¹¦Ð§»Ö¸´¡£¡£¡£ÕâЩЧ¹ûÅú×¢£¬£¬£¬EVsABPCÊÇÒ»ÖÖ¼«¾ßDZÁ¦µÄSCIÖÎÁƺòÑ¡¼Æ»®¡£¡£¡£

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

ͼ½âÕªÒª

IF=12.2
Journal of Hazardous Materials

S-Òì±û¼×²Ý°·£¨S-MET£©ÊÇÎÒ¹úÉú²úºÍʹÓÃÁ¿×î´óµÄ³ý²Ý¼ÁÖ®Ò»£¬£¬£¬Æä»¯Ñ§ÌØÕ÷µ¼ÖÂÆä¿ÉÔÚÍÁÈÀÖг¤ÆÚ±£´æÒÔ¼°ÈÝÒ×ͨ¹ýÁÜÈܺͳÁ½µÎÛȾµØ±íË®ºÍµØÏÂË®£¬£¬£¬×îÖÕÓ°ÏìÖ²ÎïÉú³¤ºÍͨ¹ýʳÎïÁ´Î£º¦ÈËÀàÉúÃü¿µ½¡¡£¡£¡£¼øÓÚÏÖÓмì²âÒªÁìµÄ¾ÖÏÞÐԺͶԸßЧÆÊÎö¼¼ÊõµÄÆÈÇÐÐèÇ󣬣¬£¬¸ÃÑо¿ÒÔS-metolachlorΪ¹¤¾ß£¬£¬£¬Ê¹Óò¸È鶯Îï±í´ïϵͳÌìÉúÏà¹ØÖØ×鿹Ìå¡£¡£¡£ÔÚÀֳɱí´ï¿¹ÌåµÄ»ù´¡ÉÏ£¬£¬£¬Àֳɽ¨ÉèÁË»ùÓÚÕâЩ¿¹ÌåµÄÃâÒ߯ÊÎöÒªÁ죬£¬£¬ÓÃÓÚ¼à²âÇéÐÎË®ÑùÖеÄS-Òì±û¼×²Ý°·²ÐÁô¡£¡£¡£icELISAЧ¹ûÏÔʾ£¬£¬£¬ÖØ×鿹ÌåµÄѸËٶȺÍÌØÒìÐÔÓëÇ×±¾µ¥¿¹ÏàËÆ£¬£¬£¬¿É¼á³ÖÔ­ÓеÄÉúÎïѧ»îÐÔ£¬£¬£¬¹ØÓÚ½­Ë®¡¢Å©ÌïË®ºÍ×ÔÀ´Ë®ÖеÄS-MET£¬£¬£¬¾ßÓÐÓÅÒìµÄ׼ȷÐÔºÍÖØ¸´ÐÔ¡£¡£¡£

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

ͼ½âÕªÒª

IF=10.7
Biosensors and Bioelectronics

ϸСRNA£¨miRNA£©ÊÇÒ»ÀàСµÄ·Ç±àÂëRNA·Ö×Ó£¬£¬£¬Í¨¹ýÓëÌØ¶¨°Ð»ùÒòµÄÐÅʹRNA£¨mRNA£©Ï໥×÷ÓÃÀ´µ÷¿Ø»ùÒò±í´ï¡£¡£¡£miRNAÔÚ¶àÖÖ¼²²¡µÄ±¬·¢¡¢Éú³¤Àú³ÌÖÐÊÎÑÝ×ÅÖ÷Òª½ÇÉ«£¬£¬£¬±»ÒÔΪÊǼ«¾ßDZÁ¦µÄ¼²²¡ÉúÎï±ê¼ÇÎï¡£¡£¡£¸ÃÑо¿Ê¹ÓÃCRISPR/Cas12a¿ª·¢ÁËÒ»ÖÖΪDBmRCAµÄÐÂÐÍmiRNA¼ì²â¼¼Êõ¡£¡£¡£¸Ã¼¼ÊõʹÓÃÎÞÅþÁ¬Ã¸µÄÑÆÁå̽ÕëºÍ¸ßѸËٶȵÄCRISPR/Cas12aÐźÅÊä³ö²ßÂÔ£¬£¬£¬ÊµÏÖÁËÔÚ30·ÖÖÓÄÚ¶ÔmiRNAµÄ¸ß¾«¶È¶¨Á¿ÆÊÎö¡£¡£¡£Ñо¿ÍŶÓͨ¹ýÁÙ´²Ñù±¾ÑéÖ¤Á˸ü¼ÊõµÄÓÐÓÃÐÔ£¬£¬£¬·¢Ã÷miR-200aºÍmiR-126Ôڷΰ©×éÖ¯Öеıí´ïˮƽÏÔÖø½µµÍ£¬£¬£¬ÇҸü¼ÊõÓë¹Å°åÒªÁìЧ¹ûÒ»Ö¡£¡£¡£DBmRCA¼¼Êõ¾ßÓÐʱ¼äЧÂʸߡ¢Ñ¸ËÙ¶ÈÇ¿ºÍ²Ù×÷Á÷³Ì¼ò»¯µÈÓŵ㣬£¬£¬ÎªÁÙ´²miRNAÆÊÎöÌṩÁËÒ»ÖÖ¿É¿¿µÄ¹¤¾ß£¬£¬£¬ÓÐÍûÖúÁ¦·Î°©µÄÔçÆÚÕï¶ÏºÍÖÎÁÆ¡£¡£¡£

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

ͼ½âÕªÒª

FAQ

ÎÈתÖêÓë˲תÖêÓкÎÇø±ð£¿£¿£¿£¿
ÎÈתÖêºÍ˲תÖêµÄÖ÷񻂿±ðÔÚÓÚ»ùÒò±í´ïµÄÒ»Á¬Ê±¼äºÍÎȹÌÐÔ£º
˲תÖꡪĿµÄ»ùÒòÔÚϸ°ûÄÚ¶ÌÔݱí´ï£¬£¬£¬Í¨³£Ò»Á¬ÊýСʱµ½ÊýÌ죬£¬£¬ÊÊÓÃÓÚ¶ÌÆÚʵÑé¡£¡£¡£
ÎÈתÖꡪĿµÄ»ùÒòÎȹÌÕûºÏµ½Ï¸°û»ùÒò×éÖУ¬£¬£¬Äܹ»ºã¾Ã±í´ï£¬£¬£¬ÊÊÓÃÓÚºã¾ÃÑо¿ºÍÉú²ú¡£¡£¡£
»ùÒò¹ý±í´ï¿ÉÒÔ×ÊÖúÑо¿Ìض¨»ùÒòµÄ¹¦Ð§£¬£¬£¬Õ¹ÏÖÆäÔÚÉúÎïÌåÄÚµÄ×÷ÓûúÖÆ¡£¡£¡£ËüÒ²³£ÓÃÓÚÒ©Îïɸѡ¡¢ÒßÃ翪·¢ºÍÂѰ×ÖÊÉú²úµÈ³¡¾°ÖС£¡£¡£ÀýÈ磬£¬£¬Í¨¹ý¹ý±í´ïij¸öÖÎÁÆÂѰף¬£¬£¬¿ÉÒÔÑо¿ÆäÔÚ¼²²¡Ä£×ÓÖеÄÖÎÁÆÐ§¹û¡£¡£¡£
ÍêÃÀÕæÈËÓµÓÐ10ÄêCRISPRϸ°û¼­ÂÄÀú£¬£¬£¬ÌṩȫÇò×ÅÃûԺУ²©Ê¿×¨¼ÒÍŶÓÒ»¶ÔһЧÀÍ¡£¡£¡£
»ùÒò¹ý±í´ïÖ¸µÄÊÇͨ¹ýÖÖÖÖ¼¼ÊõÊÖ¶Îʹij¸öÌØ¶¨»ùÒòÔÚϸ°û»òÉúÎïÌåÖбí´ïˮƽÏÔÖø¸ßÓÚÕý³£Ë®Æ½¡£¡£¡£Õâͨ³£ÊÇͨ¹ýÒýÈëÌØÁíÍâ»ùÒò¿½±´»òʹÓÃÇ¿Æô¶¯×ÓÇý¶¯»ùÒò±í´ïÀ´ÊµÏֵġ£¡£¡£

ÁªÏµÍêÃÀÕæÈË

*
*
Ñ¡Ôñ¹ú¼Ò
*
ȪԴ£º
ÁªÏµÍêÃÀÕæÈË
*
*
*
ȪԴ£º
? service online

  • ÁôÑÔ
  • You can send email to contact us.
    ÓÊÏä
  • You can send email to contact us.
    µç»°
    ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾ÁªÏµµç»°
    Öйú×ܲ¿
    18102225074(΢ÐÅͬºÅ)

  •  »Øµ½¶¥²¿